Astria Therapeutics
Jill Milne is the Founder and CEO of Catabasis Pharmaceuticals, Inc., where the focus is on developing innovative therapies using the SMART Linker drug discovery platform to address complex diseases. Prior to this role, Jill served as Chief Executive Officer at Sirtris Pharmaceuticals from 2004 to 2008 and held the position of Senior Director at Pfizer from 1998 to 2004, where Jill also directed the Global Head of Drug Pfinder. Jill Milne completed a Post-Doctoral Fellowship in Biological Chemistry and Molecular Pharmacology at Harvard Medical School, following a PhD in Biochemistry from Harvard University, and a Bachelor of Arts in Biological Chemistry from Wellesley College.
This person is not in any offices
Astria Therapeutics
2 followers
With patients as their guiding stars, Astria Therapeutics’ dedicated and passionate team is devoted to bringing life-changing therapies to patients and families impacted by HAE and rare and niche allergic and immunological diseases.